Features that may predict hospital admission following outpatient therapeutic ERCP

Citation
Ky. Ho et al., Features that may predict hospital admission following outpatient therapeutic ERCP, GASTROIN EN, 49(5), 1999, pp. 587-592
Citations number
7
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
GASTROINTESTINAL ENDOSCOPY
ISSN journal
00165107 → ACNP
Volume
49
Issue
5
Year of publication
1999
Pages
587 - 592
Database
ISI
SICI code
0016-5107(199905)49:5<587:FTMPHA>2.0.ZU;2-6
Abstract
Background: Some patients are admitted following outpatient therapeutic ERC P because of adverse events. This study aimed to identify factors that may predict such admissions. Methods: We prospectively studied admissions for post-ERCP adverse events i n 415 consecutive patients undergoing outpatient therapeutic ERCP. potentia lly relevant predictors of admission were assessed by univariate analysis a nd in case of significance included in a multivariate analysis. Results: Admission was necessary in 41 patients (9.9%) because of complicat ions and in 63 (15.2%) for observation of adverse events that did not progr ess to definable complications. Potential predictors of admission were eval uated comparing patients who required more than an overnight admission (n = 63) with those who did not (n = 352). Multivariate analysis identified thr ee factors that were significant: pain during the procedure (odds ratio 3.8 : 95% CI [1.8, 7.9]), history of pancreatitis (odds ratio 2.3: 95% CI [1.1, 4.7]) and performance of sphincterotomy (odds ratio 2.2: 95% CI [1.1, 4.3]) . The presence of all these features was associated with a 66.7% likelihood of admission, whereas the absence of pain during the procedure, history of pancreatitis and performance of sphincterotomy made admission likely in on ly 11.0%, 9.8% and 10.7%, respectively, of the cases. Conclusions: The occurrence of pain during the procedure, a history of panc reatitis and the performance of sphincterotomy were independent predictors of admission following outpatient therapeutic EWCP.